These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


283 related items for PubMed ID: 3157595

  • 1. Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings.
    Cossel L, Schneider E, Kuttler B, Schmidt S, Wohlrab F, Schade J, Bochmann C.
    Exp Clin Endocrinol; 1985 Feb; 85(1):7-26. PubMed ID: 3157595
    [Abstract] [Full Text] [Related]

  • 2. Morphologic-histochemical characterization of inflammatory cells in insulitis induced by multiple subdiabetogenic doses of streptozotocin in C57B1/KsJ mice.
    Schneider E, Wohlrab F, Cossel L.
    Biomed Biochim Acta; 1984 Feb; 43(5):683-90. PubMed ID: 6236802
    [Abstract] [Full Text] [Related]

  • 3. Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies.
    Like AA, Appel MC, Williams RM, Rossini AA.
    Lab Invest; 1978 Apr; 38(4):470-86. PubMed ID: 205725
    [Abstract] [Full Text] [Related]

  • 4. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
    O'Brien BA, Harmon BV, Cameron DP, Allan DJ.
    J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J, Welsh N, Sandler S.
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [Abstract] [Full Text] [Related]

  • 8. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
    Reddy S, Elliott RB, Chang M, Hsu T, Rodrigues JA, Qiao L, Robinson E.
    Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S, Young M, Poole CA, Ross JM.
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [Abstract] [Full Text] [Related]

  • 11. The suppressive effect of cyclophosphamide on low-dose streptozotocin-induced diabetes in mice.
    Yanagawa T, Maruyama T, Takei I, Asaba Y, Takahashi T, Ishii T, Kataoka K, Saruta T, Minoshima S, Shimizu N.
    Diabetes Res; 1989 Oct; 12(2):79-83. PubMed ID: 2699444
    [Abstract] [Full Text] [Related]

  • 12. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC, Baumann E, Vezys V, Buckingham F.
    J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
    [Abstract] [Full Text] [Related]

  • 13. Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin.
    Nicoletti F, Di Marco R, Conget I, Gomis R, Edwards C, Papaccio G, Bendtzen K, Sandler S.
    J Autoimmun; 2000 Dec; 15(4):395-405. PubMed ID: 11090238
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
    Reimers JI.
    Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
    [Abstract] [Full Text] [Related]

  • 15. Antidiabetic effects of dietary administration of Aloe arborescens Miller components on multiple low-dose streptozotocin-induced diabetes in mice: investigation on hypoglycemic action and systemic absorption dynamics of aloe components.
    Beppu H, Shimpo K, Chihara T, Kaneko T, Tamai I, Yamaji S, Ozaki S, Kuzuya H, Sonoda S.
    J Ethnopharmacol; 2006 Feb 20; 103(3):468-77. PubMed ID: 16406411
    [Abstract] [Full Text] [Related]

  • 16. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
    Hassan N, Janjua MZ.
    J Ayub Med Coll Abbottabad; 2001 Feb 20; 13(3):26-30. PubMed ID: 11873395
    [Abstract] [Full Text] [Related]

  • 17. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin.
    Herold KC, Vezys V, Sun Q, Viktora D, Seung E, Reiner S, Brown DR.
    J Immunol; 1996 May 01; 156(9):3521-7. PubMed ID: 8617981
    [Abstract] [Full Text] [Related]

  • 18. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin.
    Mensah-Brown EP, Shahin A, Al-Shamisi M, Wei X, Lukic ML.
    Eur J Immunol; 2006 Jan 01; 36(1):216-23. PubMed ID: 16358360
    [Abstract] [Full Text] [Related]

  • 19. [Histotopochemical and electronmicroscopical investigations of Wistar-rats with streptozotocin diabetes (author's transl)].
    von Dorsche HH.
    Acta Histochem; 1979 Jan 01; 64(1):5-19. PubMed ID: 157664
    [Abstract] [Full Text] [Related]

  • 20. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
    Amirshahrokhi K, Dehpour AR, Hadjati J, Sotoudeh M, Ghazi-Khansari M.
    Toxicol Appl Pharmacol; 2008 Oct 01; 232(1):119-24. PubMed ID: 18671992
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.